Pregabalin
- Product NDC
- 47335-693
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pregabalin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA091157
- Marketing category
- ANDA
- Substance
- PREGABALIN
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 47335-693-08 | 100 CAPSULE in 1 BOTTLE (47335-693-08) | 20191204 | | No | Historical |
| 47335-693-18 | 1000 CAPSULE in 1 BOTTLE (47335-693-18) | 20191204 | | No | Historical |
| 47335-693-83 | 30 CAPSULE in 1 BOTTLE (47335-693-83) | 20191204 | | No | Historical |
| 47335-693-88 | 100 CAPSULE in 1 BOTTLE (47335-693-88) | 20191204 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| ee7b9119-e88f-48ad-ae97-55e53374e62f | These highlights do not include all the information needed to use PREGABALIN CAPSULES safely and effectively. See full prescribing information for PREGABALIN CAPSULES. PREGABALIN capsules, for oral use CV Initial U.S. Approval: 2004 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2023-12-21 | Human Prescription Drug Label | 11 |